SMN, the product of the spinal muscular atrophy gene, binds preferentiallyto dimethylarginine-containing protein targets

Citation
Wj. Friesen et al., SMN, the product of the spinal muscular atrophy gene, binds preferentiallyto dimethylarginine-containing protein targets, MOL CELL, 7(5), 2001, pp. 1111-1117
Citations number
39
Categorie Soggetti
Cell & Developmental Biology
Journal title
MOLECULAR CELL
ISSN journal
10972765 → ACNP
Volume
7
Issue
5
Year of publication
2001
Pages
1111 - 1117
Database
ISI
SICI code
1097-2765(200105)7:5<1111:STPOTS>2.0.ZU;2-C
Abstract
The survival of motor neurons protein (SMN), the product of the neurodegene rative disease spinal muscular atrophy (SMA) gene, functions as an assembly factor for snRNPs and likely other RNPs. SMN binds the arginine- and glyci ne-rich (RG) domains of the snRNP proteins SmD1 and SmD3. Specific arginine s in these domains are modified to dimethylarginines, a common modification of unknown function. We show that SMN binds preferentially to the dimethyl arginine-modified RG domains of SmD1 and SmD3. The binding of other SMN-int eracting proteins is also strongly enhanced by methylation. Thus, methylati on of arginines is a novel mechanism to promote specific protein-protein in teractions and appears to be key to generating high-affinity SMN substrates . It is reasonable to expect that protein hypomethylation may contribute to the severity of SMA.